Laboratorios Farmaceuticos Rovi, S.A. (VIE:ROVI)
Austria flag Austria · Delayed Price · Currency is EUR
80.25
-0.65 (-0.80%)
Last updated: Mar 6, 2026, 1:00 PM CET

VIE:ROVI Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
97.9827.1925.32124.9599.04
Short-Term Investments
0.620.830.110.090.1
Cash & Short-Term Investments
98.628.0225.44125.0399.14
Cash Growth
251.93%10.15%-79.66%26.13%86.22%
Accounts Receivable
163.31114.83124.55160.23129.8
Other Receivables
12.0412.6115.9121.0627.83
Receivables
175.36127.44140.46181.28157.63
Inventory
287.98329.95337.97311.94245.47
Prepaid Expenses
3.192.692.732.031.79
Other Current Assets
1.591.512.742.792.33
Total Current Assets
566.71489.61509.33623.07506.36
Property, Plant & Equipment
330.74286.62253.65215.54181.78
Long-Term Investments
19.1619.520.592.22.07
Goodwill
2.7----
Other Intangible Assets
33.1833.9527.7429.1431.51
Long-Term Deferred Tax Assets
3.22.262.342.083.85
Long-Term Deferred Charges
--6.166.67.05
Other Long-Term Assets
-0.070.070.070.07
Total Assets
955.69832.02799.88878.7732.68
Accounts Payable
84.7589.93109.89125.8799.4
Accrued Expenses
30.2333.1928.8331.6724.6
Current Portion of Long-Term Debt
22.2617.848.068.272.98
Current Portion of Leases
6.365.855.134.463.44
Current Income Taxes Payable
4.42.385.26-0.68
Current Unearned Revenue
29.645.2539.51115.3958.12
Other Current Liabilities
3.582.213.178.231.17
Total Current Liabilities
181.22156.65199.84293.89190.39
Long-Term Debt
83.8880.538.5846.0452.52
Long-Term Leases
9.3310.2213.6713.414.22
Long-Term Unearned Revenue
5.462.752.793.323.79
Long-Term Deferred Tax Liabilities
0.160.371.520.680.78
Other Long-Term Liabilities
0.19----
Total Liabilities
280.24250.48256.39357.32261.7
Common Stock
3.073.073.243.243.36
Additional Paid-In Capital
87.6487.6487.6487.6487.64
Retained Earnings
578.93486.89556.21456.7446.1
Treasury Stock
-5.17-5.55-107.68-27.56-66.12
Comprehensive Income & Other
-0.05-0.02-0.02-0.01-0
Total Common Equity
664.42572.03539.39520.01470.98
Minority Interest
11.049.514.111.37-
Shareholders' Equity
675.46581.54543.49521.38470.98
Total Liabilities & Equity
955.69832.02799.88878.7732.68
Total Debt
121.82114.4165.4372.1773.16
Net Cash (Debt)
-23.22-86.39-39.9952.8725.97
Net Cash Growth
---103.55%-
Net Cash Per Share
-0.45-1.69-0.750.990.47
Filing Date Shares Outstanding
51.1551.1551.8253.3754.85
Total Common Shares Outstanding
51.1551.1551.8253.3754.85
Working Capital
385.49332.96309.49329.19315.97
Book Value Per Share
12.9911.1810.419.748.59
Tangible Book Value
628.53538.08511.65490.87439.46
Tangible Book Value Per Share
12.2910.529.879.208.01
Land
81.7974.860.6545.1237.25
Machinery
445.19404.19372.97303.78275.44
Construction In Progress
22.0911.018.4740.1728.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.